Advances in ICD Lead Technology

Mirowski M, Reid PR, Mower MM, Watkins L, Gott VL, Schauble JF, Langer A, Heilman MS, Kolenik SA, Fischell RE, Weisfeldt ML. Termination of malignant ventricular arrhythmia with an implanted automatic defibrillator in human beings. N Engl J Med 1980;303:322–324. Saksena S, Parsonnet V. Implantation of a cardioverter/ defibrillator without thoracotomy using a triple-electrode system. JAMA 1988;259:69–72. Bardy GH, Johnson G, Poole JE, Dolack GL, Kudenchuk PJ, Kelso D, Mitchell R, Mehra R, Hofer B. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation 1993;88:543–547. Jung W, Matthias M, Moosdorf R, Luderitz B. Failure of an implantable cardioverter-defibrillator to redetect ventricular fibrillation in patients with a nonthoracotomy lead system. Circulation 1992;86(Suppl IV):IV-1217–IV-1222. Ellis JR, Martin DT, Venditti FJ. Appropriate sensing of ventricular fibrillation after failed shocks in a transvenous cardioverter-defibrillator system. Circulation 1994;90:1820–1825. Lang DJ, Heil JE, Hahn SJ, Lindstrom CC, Derfus DL. Implantable cardioerter defibrillator lead technology: Improved performance and lower defibrillation thresholds. PACE 1995;18(Part II):548–559. Luria DM, Lexvold NY, Rasmussen MJ, Glikson M, Hayes DL, Hammill SC, Friedman PA. Endovascular ICD lead failure: The role of lead body design. PACE 2000;23:719 (abstract). Lawton JS, Ellenbogen KA, Wood MA, Stambler BS, Herre JM, Nath S, Bernstein RC, DiMarco JP, Haines DE, Szentpetery S, Baker LD, Damiano RJ. Sensing lead-related complications in patients with transvenous implantable cardioverter-defibrillators. Am J Cardiol 1996;78: 647–651.